Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Similac claim

This article was originally published in The Tan Sheet

Executive Summary

Appeals court ruling allowing Abbott Labs to use the "1st Choice of Doctors" claim on infant formula "violates the intent of the Lanham Act by rendering evidence of consumer perception legally irrelevant," Mead Johnson tells the U.S. Supreme Court. The Bristol-Myers Squibb division, which markets Enfamil formula, seeks reversal of a Chicago federal appeals court decision finding the claim is not misleading (1"The Tan Sheet" Jan. 17, p. 4). In an opposition brief to the high court, Abbott asserts the appeals court properly ruled "consumer research may not be used to determine the level of substantiation...that an advertiser should possess in order to render its advertising truthful"
Advertisement

Related Content

Enfamil Breast Milk Composition Claims Should Be Modified - NARB
Enfamil Breast Milk Composition Claims Should Be Modified - NARB
Enfamil Breast Milk Composition Claims Should Be Modified - NARB
Similac "1st Choice Of Doctors" Claim Injunction Reversed
Similac "1st Choice Of Doctors" Claim Injunction Reversed

Topics

Advertisement
UsernamePublicRestriction

Register

PS091601

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel